CIBC Bank USA’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-3,460
Closed -$416K 274
2014
Q4
$416K Hold
3,460
0.07% 189
2014
Q3
$506K Hold
3,460
0.1% 165
2014
Q2
$578K Sell
3,460
-130
-4% -$23.1K 0.11% 155
2014
Q1
$712K Hold
3,590
0.15% 125
2013
Q4
$686K Hold
3,590
0.15% 144
2013
Q3
$607K Sell
3,590
-3,510
-49% -$545K 0.15% 151
2013
Q2
$1.08M Buy
+7,100
New +$1.01M 0.06% 175

Other funds holding CLB

CIBC Bank USA's CLB Position: Q1 2015 in Review

CIBC Bank USA sold out of Core Laboratories (CLB) in Q1 2015, closing a stake of 3,460 shares — an estimated $416K sold.

CIBC Bank USA first reported a position in CLB in Q2 2013 and held it in 7 quarters. The position peaked at $1.08M in Q2 2013. 347 funds tracked by Wall St. Rank hold CLB as of Q1 2015.

  • CIBC Bank USA reported no remaining Core Laboratories position as of Q1 2015 after selling out during the quarter.
  • CIBC Bank USA sold 3,460 Core Laboratories shares in Q1 2015, an estimated $416K.
  • CIBC Bank USA first reported a position in Core Laboratories in Q2 2013 and held it in 7 quarters.
  • CIBC Bank USA's Core Laboratories position peaked at $1.08M in Q2 2013.
  • 347 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2015.

Based on CIBC Bank USA's 13F filing for Q1 2015, filed 9 Apr 2015.